Literature DB >> 8624109

Defective protein kinase C alpha leads to impaired secretion of soluble beta-amyloid precursor protein from Alzheimer's disease fibroblasts.

S Govoni1, M Racchi, S Bergamaschi, M Trabucchi, F Battaini, A Bianchetti, G Binetti.   

Abstract

The present study shows that cultured fibroblasts from sporadic AD patients present: a) reduced (-30%) cytosolic protein kinase C (PKC) activity; b) increased KD of phorbol ester binding (+94%) in cytosolic fractions; c) reduced (-30%) soluble protein kinase C alpha immunoreactivity; d) lower (-27.5%) basal soluble APP secretion and e) reduced soluble APP secretion in response to low phorbol ester concentrations (over threefold difference using 9 nM phorbol-12,13-dibutyrate-PdBu). Since the PKC-stimulated secretion of APP leads to the cleavage of the precursor within the amyloidogenic beta-A4 fragment, the reduced PKC activity in AD patients may lead to accumulation of potentially amyloidogenic or toxic APP fragments. A defect in the secretion of soluble amyloid beta-protein precursor is indeed suggested by literature data on familial AD fibroblasts as well as by the reported results.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8624109     DOI: 10.1111/j.1749-6632.1996.tb34442.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  7 in total

1.  Hyperactivation of mitogen-activated protein kinase increases phospho-tau immunoreactivity within human neuroblastoma: additive and synergistic influence of alteration of additional kinase activities.

Authors:  F J Ekinci; T B Shea
Journal:  Cell Mol Neurobiol       Date:  1999-04       Impact factor: 5.046

Review 2.  Age-related alteration of PKC, a key enzyme in memory processes: physiological and pathological examples.

Authors:  A Pascale; S Govoni; F Battaini
Journal:  Mol Neurobiol       Date:  1998-02       Impact factor: 5.590

Review 3.  Isoenzymes of protein kinase C: differential involvement in apoptosis and pathogenesis.

Authors:  E M Deacon; J Pongracz; G Griffiths; J M Lord
Journal:  Mol Pathol       Date:  1997-06

Review 4.  Ionic and signal transduction alterations in Alzheimer's disease: relevance of studies on peripheral cells.

Authors:  R Etcheberrigaray; S Bhagavan
Journal:  Mol Neurobiol       Date:  1999 Oct-Dec       Impact factor: 5.590

5.  Searching for disease modifiers-PKC activation and HDAC inhibition - a dual drug approach to Alzheimer's disease that decreases Abeta production while blocking oxidative stress.

Authors:  Alan P Kozikowski; Yihua Chen; Tapadar Subhasish; Nancy E Lewin; Peter M Blumberg; Zhenyu Zhong; Melissa A D'Annibale; Weng-Long Wang; Yong Shen; Brett Langley
Journal:  ChemMedChem       Date:  2009-07       Impact factor: 3.466

6.  Fleshing out the amyloid cascade hypothesis: the molecular biology of Alzheimer's disease.

Authors:  S Lovestone
Journal:  Dialogues Clin Neurosci       Date:  2000-06       Impact factor: 5.986

7.  Protein Kinase Cɛ in the Platelet and Hippocampal Tissue as a Diagnostic Biological Marker in Alzheimer Disease.

Authors:  Sara Amiri; Kayhan Azadmanesh; Marzieh Dehghan Shasaltaneh; Baharak Khoshkholgh-Sima; Nasser Naghdi
Journal:  Basic Clin Neurosci       Date:  2019-11-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.